Skip to content

Promoting Healing of Nerves Through Electrical Stimulation

Promoting Healing of Nerves Through Electrical Stimulation

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04662320
Acronym
PHONES
Enrollment
100
Registered
2020-12-10
Start date
2021-09-01
Completion date
2025-12-31
Last updated
2024-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cubital Tunnel Syndrome, Nerve Compression, Nerve Injury, Ulnar Neuropathies

Keywords

Therapeutic Electrical Stimulation, Nerve Regeneration, Nerve Healing, Nerve Injury, Cubital Tunnel, Ulnar Nerve

Brief summary

This study is evaluating a new therapeutic use of electrical stimulation to promote nerve healing and improve functional recovery following surgical intervention for nerve compression. A single dose of the therapeutic stimulation is delivered as part of the surgical intervention to address compression of the ulnar nerve at the elbow.

Detailed description

Preliminary research has shown that delivering a brief period of electrical stimulation following nerve repair promotes nerve healing and functional recovery. This study is investigating the use of a single dose of therapeutic electrical stimulation to promote nerve healing. The therapy is delivered as part of the surgical intervention to address compression of the ulnar nerve at the elbow, commonly referred to as Cubital Tunnel Syndrome.

Interventions

Single use medical device, consisting of electric stimulator and intraoperative lead. Therapy consists of single, 10 minute dose delivered proximal to site of decompression/repair. Other Name: Checkpoint BEST System

Sponsors

Congressionally Directed Medical Research Programs
CollaboratorFED
Checkpoint Surgical Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Electrodiagnostic evidence of ulnar neuropathy at the elbow. * Are candidates for surgical intervention. * Evidence of motor involvement such as intrinsic muscle atrophy or weakness. * Are age 18-80 years. * Signed and dated informed consent form.

Exclusion criteria

* Severe comorbid condition, such as arrythmia or congestive heart failure, preventing surgery * Previous history or current transection of ulnar nerve, or concomitant upper extremity nerve injury * Global peripheral neuropathy affecting the hands * Age less than 18 or greater than 80 years * Un-affected hand maximum grip strength \<12kg

Design outcomes

Primary

MeasureTime frameDescription
Change in Grip Strength at 1 year.1 yearChange in grip strength at 1 year from baseline (pre-operative) assessment.

Secondary

MeasureTime frameDescription
Lateral Pinch StrengthPre-surgery, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 yearMaximum lateral pinch strength
2-point discriminationPre-surgery, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 yearEvaluation of sensory function, measuring tactile discrimination.
Semmes-Weinstein Monofilament TestingPre-surgery, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 yearEvaluation of sensory function, measuring pressure detection threshold.
Medical Research Council (MRC) motor grading.Pre-surgery, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 yearGrading of muscle strength on 0 to 5 scale, with higher score representing greater function.
Maximal finger spread measurement.Pre-surgery, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 yearMeasurement of maximal finger spread.
Grip StrengthPre-surgery, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 yearMaximum grip strength
Patient Reported Outcome Measurement System (PROMIS) Pain InterferencePre-surgery, 10 days, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 yearQuestionnaire providing patient reported estimate of interference of pain on daily activities on a 0-100 scale with \>50 representing greater than normal pain interference on daily activities.
Michigan Hand Questionnaire (MHQ)Pre-surgery, 10 days, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 yearMHQ is a patient reported estimate of hand function on a 0-100 scale with a higher number indication greater hand function.
Nerve Conduction Velocity (NCV)Pre-surgery, 3 months, and 7 monthsMeasurement of how quickly an electrical impulse moves along the nerve.
Electromyography (EMG)Pre-surgery, 3 months, and 7 monthsMeasurement of the electrical activity in a muscle.
Patient Reported Outcome Measurement System (PROMIS) Upper Extremity FunctionPre-surgery, 10 days, 6 weeks, 3 months, 5 months, 7 months, 9 months, and 1 yearQuestionnaire providing patient reported estimate of upper extremity function on a 0-100 scale with \>50 representing greater normal function.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026